X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2278) 2278
Publication (112) 112
Book Review (17) 17
Book Chapter (2) 2
Magazine Article (2) 2
Dissertation (1) 1
Newsletter (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
heparin, low-molecular-weight - administration & dosage (2270) 2270
humans (2104) 2104
anticoagulants - administration & dosage (1236) 1236
female (1130) 1130
male (1039) 1039
middle aged (681) 681
adult (663) 663
index medicus (649) 649
heparin, low-molecular-weight - adverse effects (639) 639
heparin, low-molecular-weight - therapeutic use (637) 637
aged (628) 628
heparin - administration & dosage (498) 498
hematology (436) 436
anticoagulants - therapeutic use (425) 425
risk factors (423) 423
treatment outcome (423) 423
anticoagulants - adverse effects (422) 422
heparin (355) 355
peripheral vascular disease (352) 352
fibrinolytic agents - administration & dosage (339) 339
molecular-weight heparin (321) 321
prevention (297) 297
postoperative complications - prevention & control (293) 293
injections, subcutaneous (291) 291
venous thromboembolism (288) 288
thromboembolism - prevention & control (282) 282
thromboembolism (267) 267
pregnancy (266) 266
deep-vein thrombosis (264) 264
unfractionated heparin (263) 263
drug administration schedule (259) 259
venous thrombosis - drug therapy (259) 259
anticoagulants (258) 258
thrombosis (253) 253
time factors (249) 249
aged, 80 and over (248) 248
surgery (248) 248
enoxaparin (244) 244
prospective studies (241) 241
low molecular weight heparin (238) 238
dose-response relationship, drug (231) 231
venous thrombosis - prevention & control (231) 231
hemorrhage - chemically induced (230) 230
animals (229) 229
medicine, general & internal (219) 219
heparin - adverse effects (199) 199
administration, oral (198) 198
retrospective studies (197) 197
venous thromboembolism - prevention & control (188) 188
warfarin - administration & dosage (184) 184
low-molecular-weight heparin (182) 182
venous thrombosis (177) 177
heparin - therapeutic use (176) 176
heparin, low-molecular-weight - pharmacokinetics (170) 170
randomized controlled trials as topic (162) 162
heparin, low-molecular-weight - pharmacology (160) 160
fibrinolytic agents - therapeutic use (159) 159
prophylaxis (159) 159
thrombosis - prevention & control (158) 158
pulmonary embolism - prevention & control (157) 157
risk (154) 154
pulmonary-embolism (151) 151
pharmacology & pharmacy (150) 150
warfarin (144) 144
recurrence (142) 142
aspirin - administration & dosage (140) 140
follow-up studies (136) 136
pulmonary embolism - drug therapy (134) 134
thrombophlebitis - prevention & control (133) 133
adolescent (130) 130
anticoagulation (129) 129
risk assessment (127) 127
therapy (126) 126
enoxaparin - administration & dosage (123) 123
clinical trials as topic (121) 121
drug therapy, combination (121) 121
pulmonary embolism (117) 117
thrombophlebitis - drug therapy (116) 116
double-blind method (113) 113
thromboprophylaxis (113) 113
cardiac & cardiovascular systems (110) 110
venous thrombosis - etiology (108) 108
practice guidelines as topic (106) 106
factor xa inhibitors (105) 105
management (105) 105
fibrinolytic agents - adverse effects (100) 100
rats (99) 99
infusions, intravenous (98) 98
venous thromboembolism - drug therapy (98) 98
care and treatment (97) 97
safety (97) 97
cancer (96) 96
thromboembolism - drug therapy (96) 96
medicine & public health (94) 94
drug therapy (92) 92
incidence (92) 92
venous thromboembolism - etiology (90) 90
anticoagulants - pharmacokinetics (89) 89
blood coagulation - drug effects (87) 87
metaanalysis (87) 87
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1816) 1816
German (195) 195
French (85) 85
Spanish (38) 38
Japanese (20) 20
Russian (20) 20
Chinese (17) 17
Polish (17) 17
Hungarian (14) 14
Norwegian (14) 14
Italian (13) 13
Swedish (13) 13
Danish (12) 12
Dutch (9) 9
Czech (7) 7
Bulgarian (6) 6
Finnish (3) 3
Serbian (2) 2
Turkish (2) 2
Lithuanian (1) 1
Portuguese (1) 1
Romanian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Cochrane database of systematic reviews, ISSN 1469-493X, 2014, Volume 12, Issue 12, p. CD006652
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2015, Volume 373, Issue 9, pp. 823 - 833
Journal Article
Journal Article
Journal Article
JAMA, ISSN 0098-7484, 02/2005, Volume 293, Issue 6, pp. 681 - 689
CONTEXT Ximelagatran, an oral direct thrombin inhibitor with a rapid onset of action and predictable antithrombotic effect, has the potential to be a simple... 
ORAL XIMELAGATRAN | ENOXAPARIN | MEDICINE, GENERAL & INTERNAL | KNEE REPLACEMENT | THERAPY | VENOUS THROMBOEMBOLISM | MELAGATRAN | INTRAVENOUS UNFRACTIONATED HEPARIN | ABSORPTION | INHIBITOR XIMELAGATRAN | SECONDARY PREVENTION | Prodrugs - administration & dosage | Recurrence | Anticoagulants - administration & dosage | Humans | Middle Aged | Male | Venous Thrombosis - complications | Heparin, Low-Molecular-Weight - therapeutic use | Warfarin - administration & dosage | Warfarin - therapeutic use | Aged, 80 and over | Adult | Female | Drug Therapy, Combination | Pulmonary Embolism - complications | Double-Blind Method | Venous Thrombosis - drug therapy | Venous Thrombosis - mortality | Anticoagulants - therapeutic use | Treatment Outcome | Azetidines - administration & dosage | Azetidines - therapeutic use | Benzylamines | Aged | Prodrugs - therapeutic use | Alanine Transaminase - metabolism | Heparin, Low-Molecular-Weight - administration & dosage | Clinical trials | Cardiac arrhythmia | Thrombolytic drugs | Medical treatment | Blood clots | Low-Molecular-Weight/administration & dosage/therapeutic use | Anticoagulants/administration & dosage/therapeutic use | Pulmonary Embolism/complications | Drug Therapy | MEDICIN OCH HÄLSOVETENSKAP | Alanine Transaminase/metabolism | Warfarin/administration & dosage/therapeutic use | 80 and over | Azetidines/administration & dosage/therapeutic use | Combination | Prodrugs/administration & dosage/therapeutic use | Venous Thrombosis/complications/drug therapy/mortality | Heparin | MEDICAL AND HEALTH SCIENCES
Journal Article
Journal Article
Circulation, ISSN 0009-7322, 2014, Volume 129, Issue 7, pp. 764 - 772
Dabigatran and warfarin have been compared for the treatment of acute venous thromboembolism (VTE) in a previous trial. We undertook this study to extend those... 
Antagonists & inhibitors | Recurrence | Thrombin | Warfarin | Hemorrhage | Venous thromboembolism | CARDIAC & CARDIOVASCULAR SYSTEMS | FONDAPARINUX | THROMBOSIS | MOLECULAR-WEIGHT HEPARIN | RIVAROXABAN | INITIAL TREATMENT | PERIPHERAL VASCULAR DISEASE | ORAL ANTICOAGULANT-THERAPY | APIXABAN | UNFRACTIONATED HEPARIN | Anticoagulants - administration & dosage | Follow-Up Studies | Humans | Middle Aged | Heparin - administration & dosage | Heparin, Low-Molecular-Weight - adverse effects | Warfarin - adverse effects | Male | Antithrombins - administration & dosage | Dabigatran | Heparin - adverse effects | Warfarin - administration & dosage | Venous Thromboembolism - drug therapy | Young Adult | Benzimidazoles - administration & dosage | Adult | Female | Benzimidazoles - adverse effects | Venous Thromboembolism - epidemiology | beta-Alanine - analogs & derivatives | Acute Disease | beta-Alanine - adverse effects | Double-Blind Method | Hemorrhage - epidemiology | Risk Factors | beta-Alanine - administration & dosage | Anticoagulants - adverse effects | Antithrombins - adverse effects | Adolescent | Aged | Hemorrhage - chemically induced | Heparin, Low-Molecular-Weight - administration & dosage | Usage | Care and treatment | Dabigatran etexilate | Thromboembolism | Anticoagulants | Benzimidazoles | Heparin, Low-Molecular-Weight | Life Sciences | Venous Thromboembolism | Antithrombins | Heparin | beta-Alanine
Journal Article